⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Qsif Sector Rotation Long-Short Fund - Regular Plan - Growth | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | QSIF | HDFC MF |
| Category | Equity - Sector Rotation Long-Short Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹10.31 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Sandeep Tandon | Nikhil Mathur |
| Inception | 15 May 2026 | 04 Oct 2023 |
| Returns | ||
| 1Y | — | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 2.86% | 29.15% |
| Risk | ||
| 5.63 | 14.07 | |
| 0.06 | 0.59 | |
| 0.10 | 1.59 | |
| 0.99 | 21.67 | |
| 0.21 | 3.48 | |
| -3.36% | -9.23% | |
| Costs | ||
| Expense Ratio | 4.36% | 1.03% |
| Exit Load | 3% on or before 30D, NIL after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹10,00,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
QSIF82%
HDFC MF82%
18.5%Only 18.5% of holdings by weight are common between QSIF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingQSIFHDFC MF
Divi's Laboratories Ltd.7.18%9.39%
Sun Pharmaceutical Industries Ltd.5.68%8.28%
Lupin Ltd.5.28%3.55%
Glenmark Pharmaceuticals Ltd.5.61%2.09%
Category context: Equity vs Equity. Open the full Screener →